Effectiveness and composition of emotional cultivation groups for Taiwanese youth with emotion regulation difficulties.

Psychother ResFeb 5, 2026 (epub)
Clinical ResearchPsychiatryPediatrics

Li-Fei Wang, Dennis M Kivlighan, Meifen Wei et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial evaluated semi-structured emotional cultivation counseling (BEAR) groups in 232 Taiwanese students referred for emotion regulation difficulties in school settings. Students were assigned to 20 BEAR groups or a waitlist control, with relational outcomes assessed before intervention and at three-month follow-up. Compared with controls, participants in BEAR groups improved more in Relational Problem-Solving, but not in Closeness to Others. Within BEAR groups, greater variation in students’ pretest friendship-approach goals was associated with greater improvement in Relational Problem-Solving.

Key findings

  • BEAR participants showed significantly greater improvement in Relational Problem-Solving than waitlist controls.
  • The intervention did not produce significantly greater improvement in Closeness to Others than the waitlist condition.
  • Within BEAR groups, greater heterogeneity in pretest Friendship-Approach goals was associated with greater change in Relational Problem-Solving.

Why it matters

The findings suggest that a culturally grounded, group-based approach may support relational problem-solving among Taiwanese youth with emotion regulation difficulties. The association between group composition and outcome also raises the possibility that differences in friendship-approach goals within groups matter, although this result does not establish that deliberately varying group composition will improve outcomes.

What to keep in mind

Outcomes were assessed at a three-month follow-up, and the abstract reports improvement in one relational outcome but not the other. The association between group composition and change is not evidence that group heterogeneity caused the improvement.

Source

Published in Psychother Res. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.